|
【参考文献】
1 Grant MB, Afzal A. The role of growth factors in the pathogenesis of diabetic retinopathy. Exp Opin Invest Drugs 2004;13( 10):12751293
2 Lee YC. The involvement of VEGF in endothelial permeability: a target for antiinflammatory therapy. Curr Opin Investing Drugs 2005;6(11):11241130
3 Bates DO, Cui TG. VEGF16Sb, an inhibitory splice variant of vascular endothelial growth factor, is downregulated in renal cell carcinoma.Cancer Res 2002;62:41234131
4 Woolard I, Wang WY, Bevan HS, et al. VEGF16Sb, an inhibitory vascular endothelial growth factor splice variant: mechanism of action,in vivo effect on angiogenesis and endogenous protein expression. CancerRes 2004;64(21):78227835
5 Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci(Lond) 2005;109(3):227241
6 Das A, McGuire PG. Retinal and choroidal angiogenesis pathophysiology and strategies for inhibition. Prog Retin Eye Res 2003;22(6):721748
7 Tammela T. The biology of vascular endothelial growth factors. CardiovascRes 2005;65(3): 550563
8 Nishijima K, Ng YS, Zhong L. Vascular endothelial growth factorA is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am I Pathol 2007;169(7):1418
9 Sydorova M, Lee MS. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy. Ophthalmic Res 2005;37(4):188190
10 McLeod DS, Taomoto M, Otsuji T, et al. Quantifying changes in RPE and choroidal vasculature in eyes with agerelated macular degeneration. Invest Ophthalmol Vis Sci 2002;43(6):19861993
11 Ambati J, Ambati BK. Agerelated macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48(3):257293
12 SchmidBmnclik N, BurgiTaboada C. A strocyte responses to injury: VEGF simultaneously modulates cell death and proliferation. Am J PhysiolRegul lntegr Comp Physiol 2008;295(3):864873
13 Leske DA, Wu J. The relationship of retinal VEGF and retinal IGF1 mRNA with neovascularizationinanacidosisinduced model of retinopathy of prematurity. Curr Eye Res 2006;31(2):163169
14 Distler H, Hirth A. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 2003;47(3):149161
15 Watanabe D. Transcription factor Ets1 mediates ischemia and vascular endothelial growth factordependent retinal neovascularization. Am J Pathol 2004;164(5):18271835
16 Kim I, Kim HG, So IN. AngiopoietinI regulates endothelial cell survival through the phosphatidylinositol 3'kinase/Akt signal transduction pathway. Circ Res 2000;86(1):2429
17 Pizurki L, Zhou ZG. Angiopoietin1 inhibits endothelial permeability neutrophil adherence and IL8 production. Br J Phamacol 2003;139(2):329336
18 Papapetropoulos A, Fulton D, Mahboubi K, et al. Angiopoietinl inhibits endothelial cell apoptosis via the Akt/ surviving pathway. J BiolChem 2000;275:9102 9105
19 Kim I, Kim HG. AngiopoietinI induces endothelial sproutin through the activation of facal adhesion kinase and plasmin secretion. Circ Res 2000;86(9):952959
20 Kastrup J, Jurgensen E. Direct intramyocardial plasmid vascular endothelial growth factorA165 gene therapy in patients with stable severe angina pectoris A randomized double blind placebo controlled study: the euroinject one trial. J Am Coll Cardiol 2005;45(7):982988
21 Benest AV, Salmon AH. VEGF and angiopioetin I stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissue. Microcirculation 2006;13(6):423437
22 Kutryk MJ, Stewart DJ. Angiogenesis of the heart. Microsc Res Tech 2003;60(2):138158
23 Jiang J, Jiang N, Gao W. Augmentation of revascularization and prevention of plasma leakage by angiopoietin1 mad vascular endothelial growth factor cotransfection in rats with experimental limb ischaemia.Acta Cardiol 2006;61(2):145153
24 Hellstrom A, Perruzzi C. Low IGF1 suppress VEGFsurvival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001;98(10):58045808
25 Lambooij AC. Insulinlike growth factor1 and its receptor in neovascular agerelated macular degeneration. Invest Ophthalmol Vis Sci 2003;44(5):21922198
26 EspinosaHeMmann DG, Caieedo A, Hernamtez EP. Cousinsl bone marrowderived progenitor cells contribute to experimental ehoroMal neovascularization. Invest Ophthalmol Vis Sci 2003;44(11):49144919
27 Nagineni CN. Transforming growth factorl induces expression of vascular endothetial growth factor in human retinal pigment epithelial cells: involvement of mitogenactivated protein kinases. J Cell Physiol 2003;197(3):453462
28 Ambati J, Ambati BK. Agerelated macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48(3):257293
29 Hackett SF. Angiopoietin2 plays an important role in retinal angiogenesis. J Cell Physiol 2002;192(2):182 187
30 Umeda N, Ozaki H. Colocalization of Tie2, angiopoietin2, and vascular endothelial growth factor in fibrovascular membrane from patients with retinopathy of prematurity . Ophthalmic Res 2003;35(4):217223
31 Joussen AM, Poulaki V. Suppression of diabetic retinopathy with angiopoietin1. Am J Pathol 2002;160(5):16831693
32 Takagi H, Koyama S, Seike H. Potential role of the angiopoietin/Tie2 system in ischemiainduced retinal neovascularization. Invest Ophthalmol VisSci 2003;44(1):393402
33 Yuan HT. Angiopoietin2 is a partial agonist/antagonist of tie2 signaling in endothelium. Mol Cell Biol 2009;29(8):20112022
34 Fiedler U, Augustin HG. Angiopoietin is a link between angiogenesis and inflammation. Trends Immunol 2006;27(12):552558
35 Deng ZH, Liu SZ, Tan J. IGF1R/ IGF2R mRNA expression in the posterior sclera of chicken formdeprivation myopia. Int J OphthalmolGuoji Yanke Zazhi) 2005;5(5):929937 上一页 [1] [2] |
